Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
May 08, 2024
Managing pandemics is not just about halting the spread of disease—it's about striking a careful balance between preserving public health and minimizing disruptions to daily life and well-being. Crafting effective policies in such situations requires a deep understanding of factors including how the...
CGD NOTES
March 28, 2024
Over the past two decades, China has become a distinctive and increasingly important donor of development assistance for health (DAH). However, little is known about what factors influence China’s priority-setting for DAH. In this study, we provide an updated analysis of trends in the priorities of ...
TESTIMONY
March 21, 2024
On Thursday, March 21, 2024, CGD Senior Fellow Charles Kenny appeared before the Subcommittee on National Security, the Border, and Foreign Affairs of the House Committee on Oversight and Accountability at a hearing titled “Accountable Assistance: Reviewing Controls to Prevent Mismanagement of Forei...
Blog Post
February 26, 2024
As policymakers and financiers set their priorities for 2024, we gathered a group of experts who've been working on pandemics and pandemic financing from a range of perspectives including epidemiology, economics, insurance, policy, and advocacy. The purpose of our event was to map out the next steps...
WORKING PAPERS
November 20, 2023
Over two decades and dozens of countries, the United States Agency for International Development has refined a package of support for early-grade reading, often referred to as “structured pedagogy”, which includes textbooks, teacher training, coaching, and lesson plans.
Blog Post
November 15, 2023
During the COVID-19 pandemic, whole genomic sequencing (WGS)-based surveillance played a key role in identifying variants of concern, investigating their spread and transmissibility, and facilitating the design and optimization of medical countermeasures, including diagnostic tools and vaccines. How...
Blog Post
September 14, 2023
COVID-19 is fading from public discussion, countries’ , and hopes for a safer and fairer future are being dashed by potentially watered-down political commitments. Yet people around the world continue to feel the impacts of COVID-19 every day, other infectious disease threats have not magically gone...
Blog Post
September 05, 2023
Today the Africa Centers for Disease Control’s (ACDC) Health Economics Programme (HEP) has published a new policy brief on the cost-effectiveness of two COVID-19 oral antivirals (COAVs), a nirmatrelvir/ritonavir combination, developed by Pfizer and sold under the name Paxlovid, and Molnupiravir, dev...